Back to results
US 2010/0143376 A1Published application
Antibodies Specific for Rubella Virus
AssigneeRibovax Biotechnologies S.A.
InventorsRoberto Burioni, Massimo Clementi
Life of this patent
Estimating the term…
Abstract
The present invention provides novel antibody sequences that bind and neutralize Rubella Virus (RuV). The novel sequences can be used for the medical management of RuV infection, in particular for detecting the virus or for preparing pharmaceutical compositions. The RuV-specific antigens recognized by such antibody sequences can be identified using novel phage libraries that display peptides.
Claims17
A protein comprising a sequence having at least 90% identity with SEQ ID NO.:
- 5.
(canceled)
Dependencies are inferred from the claim text.